TABLE 1.
Sample | % of sites with eradication of bacteria after treatment witha:
|
|||||
---|---|---|---|---|---|---|
Antibiotic ointment
|
Placebo ointment
|
|||||
Triple (A) | Double (C) | Mupirocin (E) | Base (B) | Vehicle (D) | Petroleum jelly (F) | |
Pretreatment | 2 | 0 | 0 | 0 | 0 | 0 |
After 6 h of treatment | ||||||
Surface | 96* | 14 | 40* | 6 | 10 | 8 |
5 layers | 90* | 22* | 28* | 12 | 4 | 0 |
15 layers | 84* | 14 | 26* | 2 | 8 | 4 |
25 layers | 62* | 4 | 14 | 0 | 14 | 8 |
After overnight treatment | ||||||
Surface | 72* | 8 | 9 | 12 | 16 | 0 |
5 layers | 60* | 12 | 18 | 6 | 8 | 6 |
At 1 wk posttreatment | ||||||
Surface | 0 | 0 | 0 | |||
15 layers | 0 | 0 | 0 | |||
25 layers | 0 | 0 | 2 |
Eradication (0 CFU) of aerobic bacteria was determined at sites on the skin surface and in the SC. Each antibiotic-containing ointment was paired across the midline with a placebo ointment (i.e., A and B, C and D, E and F). *, P ≤ 0.01 versus placebo.